Related Experiment Video

Updated: Jun 11, 2026

Amplitude-Integrated EEG in Infants at Risk of Hypoxic-Ischemic Encephalopathy: A Feasibility Study in Road and Air Transport in Western Australia
05:15

Amplitude-Integrated EEG in Infants at Risk of Hypoxic-Ischemic Encephalopathy: A Feasibility Study in Road and Air Transport in Western Australia

Published on: June 21, 2024

Power to the paediatricians: the Australian Paediatric Research Network is born

Harriet Hiscock1, Daryl Efron, Richard Wasserman

  • 1Centre for Community Child Health, Royal Children's Hospital, Melbourne, Australia. harrriet.hiscock@rch.org.au

Journal of Paediatrics and Child Health
|July 6, 2010
PubMed

Insights

The Australian Paediatric Research Network (APRN) connects 350 pediatricians to improve research on common child health issues in secondary care. This network aims to generate relevant research ideas and enhance healthcare policy for Australian children.

Area of Science:

  • Pediatric Health Research
  • Clinical Networks
  • Secondary Care Settings

Background:

  • Tertiary institutions dominate pediatric research, often focusing on severe or isolated conditions.
  • This tertiary research focus may not always align with the daily realities faced by general pediatricians.
  • There is a need for research that reflects common child health conditions encountered in secondary care.

Purpose of the Study:

  • To establish the Australian Paediatric Research Network (APRN) to facilitate high-quality research.
  • To engage pediatricians in generating research ideas and participating in studies relevant to secondary care.
  • To improve healthcare and policy for Australian children through practice-based research.

Main Methods:

  • Established a network of 350 pediatricians across Australia.
  • Conducted a prospective audit of pediatrician caseloads to identify research priorities.
  • Developed a website to provide resources for research, including child health measures and project design tools.

Main Results:

  • The APRN has successfully engaged members and identified research priorities.
  • A prospective audit of caseloads has informed the relevance and feasibility of future studies.
  • A dedicated website is operational, offering tools to support research activities.

Conclusions:

  • The APRN is well-positioned to address research challenges in secondary care settings.
  • The network aims to conduct annual member-initiated research and multi-topic surveys.
  • The APRN is committed to overcoming challenges in time, cost, and process for pediatric research.

More Related Videos

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device07:44

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

Collection, Expansion, and Differentiation of Primary Human Nasal Epithelial Cell Models for Quantification of Cilia Beat Frequency11:13

Collection, Expansion, and Differentiation of Primary Human Nasal Epithelial Cell Models for Quantification of Cilia Beat Frequency

Published on: November 10, 2021

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...